USS Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.59M | Buy |
18,280
+78
| +0.4% | +$40.9K | 0.06% | 216 |
|
|
2025
Q1 | $11.5M | Hold |
18,202
| – | – | 0.08% | 171 |
|
|
2024
Q4 | $13M | Sell |
18,202
-1,440
| -7% | -$1.03M | 0.09% | 177 |
|
|
2024
Q3 | $20.7M | Sell |
19,642
-282
| -1% | -$297K | 0.15% | 119 |
|
|
2024
Q2 | $21M | Buy |
19,924
+398
| +2% | +$419K | 0.17% | 100 |
|
|
2024
Q1 | $18.8M | Buy |
19,526
+402
| +2% | +$387K | 0.15% | 121 |
|
|
2023
Q4 | $16.8M | Sell |
19,124
-889
| -4% | -$781K | 0.15% | 124 |
|
|
2023
Q3 | $16.5M | Buy |
20,013
+857
| +4% | +$705K | 0.18% | 116 |
|
|
2023
Q2 | $13.8M | Buy |
19,156
+253
| +1% | +$182K | 0.16% | 132 |
|
|
2023
Q1 | $15.5M | Buy |
18,903
+337
| +2% | +$277K | 0.21% | 104 |
|
|
2022
Q4 | $13.4M | Buy |
18,566
+358
| +2% | +$258K | 0.19% | 121 |
|
|
2022
Q3 | $12.6M | Sell |
18,208
-5,344
| -23% | -$3.68M | 0.18% | 121 |
|
|
2022
Q2 | $13.9M | Sell |
23,552
-1,577
| -6% | -$932K | 0.14% | 155 |
|
|
2022
Q1 | $17.6M | Buy |
25,129
+877
| +4% | +$613K | 0.14% | 148 |
|
|
2021
Q4 | $15.3M | Hold |
24,252
| – | – | 0.12% | 173 |
|
|
2021
Q3 | $14.7M | Buy |
24,252
+18,204
| +301% | +$11M | 0.12% | 168 |
|
|
2021
Q2 | $3.38M | Hold |
6,048
| – | – | 0.03% | 330 |
|
|
2021
Q1 | $2.86M | Hold |
6,048
| – | – | 0.02% | 344 |
|
|
2020
Q4 | $2.92M | Sell |
6,048
-700
| -10% | -$338K | 0.03% | 312 |
|
|
2020
Q3 | $3.78M | Hold |
6,748
| – | – | 0.04% | 259 |
|
|
2020
Q2 | $4.21M | Buy |
+6,748
| New | +$4.21M | 0.04% | 226 |
|